Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Supply, Demand and Key Producers, 2023-2029
The global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Porcine viral diarrhea is a common and frequently-occurring disease in pigs, and the most serious pathogens are porcine transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV) and porcine rotavirus (PoRV). All three pathogens can infect pigs of all ages and can cause symptoms such as vomiting, watery diarrhea and dehydration. The harm to piglets within 10 days of age is particularly serious, and the morbidity and mortality are high, up to 100%. The vaccine is inoculated at the Houhai point, and it is safe and effective for all pigs including suckling piglets and pregnant sows. It realizes the prevention of three diseases with one shot, reduces the immune stress of pigs, and reduces the labor intensity and breeding of vaccination. cost, and has a significant effect on the prevention of single infection or mixed infection of the three pathogens.
This report studies the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine total production and demand, 2018-2029, (K Doses)
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine total production value, 2018-2029, (USD Million)
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine consumption by region & country, CAGR, 2018-2029 & (K Doses)
U.S. VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine domestic production, consumption, key domestic manufacturers and share
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Doses)
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
This reports profiles key players in the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Sant? Animale, MSD Animal Health, SPAH, Nanjing Tianbang Biological Technology, Sichuan Huapai Bio-pharmaceutical and Guangdong Winsun Bio Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market, By Region:
1. How big is the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
2. What is the demand of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
3. What is the year over year growth of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
4. What is the production and production value of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
5. Who are the key producers in the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
6. What are the growth factors driving the market demand?
Porcine viral diarrhea is a common and frequently-occurring disease in pigs, and the most serious pathogens are porcine transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV) and porcine rotavirus (PoRV). All three pathogens can infect pigs of all ages and can cause symptoms such as vomiting, watery diarrhea and dehydration. The harm to piglets within 10 days of age is particularly serious, and the morbidity and mortality are high, up to 100%. The vaccine is inoculated at the Houhai point, and it is safe and effective for all pigs including suckling piglets and pregnant sows. It realizes the prevention of three diseases with one shot, reduces the immune stress of pigs, and reduces the labor intensity and breeding of vaccination. cost, and has a significant effect on the prevention of single infection or mixed infection of the three pathogens.
This report studies the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine total production and demand, 2018-2029, (K Doses)
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine total production value, 2018-2029, (USD Million)
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine consumption by region & country, CAGR, 2018-2029 & (K Doses)
U.S. VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine domestic production, consumption, key domestic manufacturers and share
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Doses)
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
This reports profiles key players in the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Sant? Animale, MSD Animal Health, SPAH, Nanjing Tianbang Biological Technology, Sichuan Huapai Bio-pharmaceutical and Guangdong Winsun Bio Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Live Vaccine
- Inactivated Vaccine
- Piglets
- Adults Pigs
- Zoetis Animal Health
- Boehringer-Ingelheim
- Merck Animal Health
- Ceva Sant? Animale
- MSD Animal Health
- SPAH
- Nanjing Tianbang Biological Technology
- Sichuan Huapai Bio-pharmaceutical
- Guangdong Winsun Bio Pharmaceutical
- Wuhan Keqian Biology
- Shanghai Hile Bio-Technology
- Harbin Pharmaceutical Group Bio-Vaccine
- Ringpu
- Shandong Huahong Bioengineering
- Weike Biotechnology
- Nanjing Tianbang Biological Technology
- China Animal Husbandry Industry
1. How big is the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
2. What is the demand of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
3. What is the year over year growth of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
4. What is the production and production value of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
5. Who are the key producers in the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Introduction
1.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Supply & Forecast
1.2.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029)
1.2.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Pricing Trends (2018-2029)
1.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Region (Based on Production Site)
1.3.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Region (2018-2029)
1.3.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Region (2018-2029)
1.3.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2018-2029)
1.3.4 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029)
1.3.5 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029)
1.3.6 China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029)
1.3.7 Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Demand (2018-2029)
2.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption by Region
2.2.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption by Region (2018-2023)
2.2.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.4 China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.5 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.6 Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.7 South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.8 ASEAN Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.9 India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
3 WORLD SWINE TRANSMISSBLE GASTROENTERITIS,PORCINE EPIDEMIC DIARRHEA AND PORCINE ROTAVIRUS VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Manufacturer (2018-2023)
3.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Manufacturer (2018-2023)
3.4 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine in 2022
3.6 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Overall Company Footprint Analysis
3.6.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Region Footprint
3.6.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Type Footprint
3.6.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Comparison
4.1.1 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Comparison
4.2.1 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Comparison
4.3.1 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023)
4.5 China Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers and Market Share
4.5.1 China Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023)
4.6 Rest of World Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Live Vaccine
5.2.2 Inactivated Vaccine
5.3 Market Segment by Type
5.3.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Type (2018-2029)
5.3.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Type (2018-2029)
5.3.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Piglets
6.2.2 Adults Pigs
6.3 Market Segment by Application
6.3.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Application (2018-2029)
6.3.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Application (2018-2029)
6.3.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Zoetis Animal Health
7.1.1 Zoetis Animal Health Details
7.1.2 Zoetis Animal Health Major Business
7.1.3 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.1.4 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Zoetis Animal Health Recent Developments/Updates
7.1.6 Zoetis Animal Health Competitive Strengths & Weaknesses
7.2 Boehringer-Ingelheim
7.2.1 Boehringer-Ingelheim Details
7.2.2 Boehringer-Ingelheim Major Business
7.2.3 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.2.4 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Boehringer-Ingelheim Recent Developments/Updates
7.2.6 Boehringer-Ingelheim Competitive Strengths & Weaknesses
7.3 Merck Animal Health
7.3.1 Merck Animal Health Details
7.3.2 Merck Animal Health Major Business
7.3.3 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.3.4 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Merck Animal Health Recent Developments/Updates
7.3.6 Merck Animal Health Competitive Strengths & Weaknesses
7.4 Ceva Sant? Animale
7.4.1 Ceva Sant? Animale Details
7.4.2 Ceva Sant? Animale Major Business
7.4.3 Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.4.4 Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Ceva Sant? Animale Recent Developments/Updates
7.4.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
7.5 MSD Animal Health
7.5.1 MSD Animal Health Details
7.5.2 MSD Animal Health Major Business
7.5.3 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.5.4 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 MSD Animal Health Recent Developments/Updates
7.5.6 MSD Animal Health Competitive Strengths & Weaknesses
7.6 SPAH
7.6.1 SPAH Details
7.6.2 SPAH Major Business
7.6.3 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.6.4 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 SPAH Recent Developments/Updates
7.6.6 SPAH Competitive Strengths & Weaknesses
7.7 Nanjing Tianbang Biological Technology
7.7.1 Nanjing Tianbang Biological Technology Details
7.7.2 Nanjing Tianbang Biological Technology Major Business
7.7.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.7.4 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
7.7.6 Nanjing Tianbang Biological Technology Competitive Strengths & Weaknesses
7.8 Sichuan Huapai Bio-pharmaceutical
7.8.1 Sichuan Huapai Bio-pharmaceutical Details
7.8.2 Sichuan Huapai Bio-pharmaceutical Major Business
7.8.3 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.8.4 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
7.8.6 Sichuan Huapai Bio-pharmaceutical Competitive Strengths & Weaknesses
7.9 Guangdong Winsun Bio Pharmaceutical
7.9.1 Guangdong Winsun Bio Pharmaceutical Details
7.9.2 Guangdong Winsun Bio Pharmaceutical Major Business
7.9.3 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.9.4 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
7.9.6 Guangdong Winsun Bio Pharmaceutical Competitive Strengths & Weaknesses
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Details
7.10.2 Wuhan Keqian Biology Major Business
7.10.3 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.10.4 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Wuhan Keqian Biology Recent Developments/Updates
7.10.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
7.11 Shanghai Hile Bio-Technology
7.11.1 Shanghai Hile Bio-Technology Details
7.11.2 Shanghai Hile Bio-Technology Major Business
7.11.3 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.11.4 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
7.11.6 Shanghai Hile Bio-Technology Competitive Strengths & Weaknesses
7.12 Harbin Pharmaceutical Group Bio-Vaccine
7.12.1 Harbin Pharmaceutical Group Bio-Vaccine Details
7.12.2 Harbin Pharmaceutical Group Bio-Vaccine Major Business
7.12.3 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.12.4 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
7.12.6 Harbin Pharmaceutical Group Bio-Vaccine Competitive Strengths & Weaknesses
7.13 Ringpu
7.13.1 Ringpu Details
7.13.2 Ringpu Major Business
7.13.3 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.13.4 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Ringpu Recent Developments/Updates
7.13.6 Ringpu Competitive Strengths & Weaknesses
7.14 Shandong Huahong Bioengineering
7.14.1 Shandong Huahong Bioengineering Details
7.14.2 Shandong Huahong Bioengineering Major Business
7.14.3 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.14.4 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Shandong Huahong Bioengineering Recent Developments/Updates
7.14.6 Shandong Huahong Bioengineering Competitive Strengths & Weaknesses
7.15 Weike Biotechnology
7.15.1 Weike Biotechnology Details
7.15.2 Weike Biotechnology Major Business
7.15.3 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.15.4 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Weike Biotechnology Recent Developments/Updates
7.15.6 Weike Biotechnology Competitive Strengths & Weaknesses
7.16 Nanjing Tianbang Biological Technology
7.16.1 Nanjing Tianbang Biological Technology Details
7.16.2 Nanjing Tianbang Biological Technology Major Business
7.16.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.16.4 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
7.16.6 Nanjing Tianbang Biological Technology Competitive Strengths & Weaknesses
7.17 China Animal Husbandry Industry
7.17.1 China Animal Husbandry Industry Details
7.17.2 China Animal Husbandry Industry Major Business
7.17.3 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.17.4 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 China Animal Husbandry Industry Recent Developments/Updates
7.17.6 China Animal Husbandry Industry Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Chain
8.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Upstream Analysis
8.2.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Mode
8.6 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Procurement Model
8.7 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Sales Model and Sales Channels
8.7.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Model
8.7.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Introduction
1.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Supply & Forecast
1.2.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029)
1.2.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Pricing Trends (2018-2029)
1.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Region (Based on Production Site)
1.3.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Region (2018-2029)
1.3.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Region (2018-2029)
1.3.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2018-2029)
1.3.4 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029)
1.3.5 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029)
1.3.6 China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029)
1.3.7 Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Demand (2018-2029)
2.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption by Region
2.2.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption by Region (2018-2023)
2.2.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.4 China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.5 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.6 Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.7 South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.8 ASEAN Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
2.9 India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029)
3 WORLD SWINE TRANSMISSBLE GASTROENTERITIS,PORCINE EPIDEMIC DIARRHEA AND PORCINE ROTAVIRUS VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Manufacturer (2018-2023)
3.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Manufacturer (2018-2023)
3.4 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine in 2022
3.6 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Overall Company Footprint Analysis
3.6.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Region Footprint
3.6.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Type Footprint
3.6.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Comparison
4.1.1 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Comparison
4.2.1 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Comparison
4.3.1 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023)
4.5 China Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers and Market Share
4.5.1 China Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023)
4.6 Rest of World Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Live Vaccine
5.2.2 Inactivated Vaccine
5.3 Market Segment by Type
5.3.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Type (2018-2029)
5.3.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Type (2018-2029)
5.3.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Piglets
6.2.2 Adults Pigs
6.3 Market Segment by Application
6.3.1 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Application (2018-2029)
6.3.2 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Application (2018-2029)
6.3.3 World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Zoetis Animal Health
7.1.1 Zoetis Animal Health Details
7.1.2 Zoetis Animal Health Major Business
7.1.3 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.1.4 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Zoetis Animal Health Recent Developments/Updates
7.1.6 Zoetis Animal Health Competitive Strengths & Weaknesses
7.2 Boehringer-Ingelheim
7.2.1 Boehringer-Ingelheim Details
7.2.2 Boehringer-Ingelheim Major Business
7.2.3 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.2.4 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Boehringer-Ingelheim Recent Developments/Updates
7.2.6 Boehringer-Ingelheim Competitive Strengths & Weaknesses
7.3 Merck Animal Health
7.3.1 Merck Animal Health Details
7.3.2 Merck Animal Health Major Business
7.3.3 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.3.4 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Merck Animal Health Recent Developments/Updates
7.3.6 Merck Animal Health Competitive Strengths & Weaknesses
7.4 Ceva Sant? Animale
7.4.1 Ceva Sant? Animale Details
7.4.2 Ceva Sant? Animale Major Business
7.4.3 Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.4.4 Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Ceva Sant? Animale Recent Developments/Updates
7.4.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
7.5 MSD Animal Health
7.5.1 MSD Animal Health Details
7.5.2 MSD Animal Health Major Business
7.5.3 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.5.4 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 MSD Animal Health Recent Developments/Updates
7.5.6 MSD Animal Health Competitive Strengths & Weaknesses
7.6 SPAH
7.6.1 SPAH Details
7.6.2 SPAH Major Business
7.6.3 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.6.4 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 SPAH Recent Developments/Updates
7.6.6 SPAH Competitive Strengths & Weaknesses
7.7 Nanjing Tianbang Biological Technology
7.7.1 Nanjing Tianbang Biological Technology Details
7.7.2 Nanjing Tianbang Biological Technology Major Business
7.7.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.7.4 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
7.7.6 Nanjing Tianbang Biological Technology Competitive Strengths & Weaknesses
7.8 Sichuan Huapai Bio-pharmaceutical
7.8.1 Sichuan Huapai Bio-pharmaceutical Details
7.8.2 Sichuan Huapai Bio-pharmaceutical Major Business
7.8.3 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.8.4 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
7.8.6 Sichuan Huapai Bio-pharmaceutical Competitive Strengths & Weaknesses
7.9 Guangdong Winsun Bio Pharmaceutical
7.9.1 Guangdong Winsun Bio Pharmaceutical Details
7.9.2 Guangdong Winsun Bio Pharmaceutical Major Business
7.9.3 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.9.4 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
7.9.6 Guangdong Winsun Bio Pharmaceutical Competitive Strengths & Weaknesses
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Details
7.10.2 Wuhan Keqian Biology Major Business
7.10.3 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.10.4 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Wuhan Keqian Biology Recent Developments/Updates
7.10.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
7.11 Shanghai Hile Bio-Technology
7.11.1 Shanghai Hile Bio-Technology Details
7.11.2 Shanghai Hile Bio-Technology Major Business
7.11.3 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.11.4 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
7.11.6 Shanghai Hile Bio-Technology Competitive Strengths & Weaknesses
7.12 Harbin Pharmaceutical Group Bio-Vaccine
7.12.1 Harbin Pharmaceutical Group Bio-Vaccine Details
7.12.2 Harbin Pharmaceutical Group Bio-Vaccine Major Business
7.12.3 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.12.4 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
7.12.6 Harbin Pharmaceutical Group Bio-Vaccine Competitive Strengths & Weaknesses
7.13 Ringpu
7.13.1 Ringpu Details
7.13.2 Ringpu Major Business
7.13.3 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.13.4 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Ringpu Recent Developments/Updates
7.13.6 Ringpu Competitive Strengths & Weaknesses
7.14 Shandong Huahong Bioengineering
7.14.1 Shandong Huahong Bioengineering Details
7.14.2 Shandong Huahong Bioengineering Major Business
7.14.3 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.14.4 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Shandong Huahong Bioengineering Recent Developments/Updates
7.14.6 Shandong Huahong Bioengineering Competitive Strengths & Weaknesses
7.15 Weike Biotechnology
7.15.1 Weike Biotechnology Details
7.15.2 Weike Biotechnology Major Business
7.15.3 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.15.4 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Weike Biotechnology Recent Developments/Updates
7.15.6 Weike Biotechnology Competitive Strengths & Weaknesses
7.16 Nanjing Tianbang Biological Technology
7.16.1 Nanjing Tianbang Biological Technology Details
7.16.2 Nanjing Tianbang Biological Technology Major Business
7.16.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.16.4 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
7.16.6 Nanjing Tianbang Biological Technology Competitive Strengths & Weaknesses
7.17 China Animal Husbandry Industry
7.17.1 China Animal Husbandry Industry Details
7.17.2 China Animal Husbandry Industry Major Business
7.17.3 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
7.17.4 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 China Animal Husbandry Industry Recent Developments/Updates
7.17.6 China Animal Husbandry Industry Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Chain
8.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Upstream Analysis
8.2.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Mode
8.6 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Procurement Model
8.7 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Sales Model and Sales Channels
8.7.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Model
8.7.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Region (2018-2023) & (K Doses)
Table 7. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Region (2024-2029) & (K Doses)
Table 8. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share by Region (2018-2023)
Table 9. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share by Region (2024-2029)
Table 10. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 11. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 12. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Major Market Trends
Table 13. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Doses)
Table 14. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption by Region (2018-2023) & (K Doses)
Table 15. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Forecast by Region (2024-2029) & (K Doses)
Table 16. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Producers in 2022
Table 18. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Manufacturer (2018-2023) & (K Doses)
Table 19. Production Market Share of Key Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Producers in 2022
Table 20. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 21. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Company Evaluation Quadrant
Table 22. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Site of Key Manufacturer
Table 24. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Type Footprint
Table 25. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Application Footprint
Table 26. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Competitive Factors
Table 27. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine New Entrant and Capacity Expansion Plans
Table 28. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 31. United States VS China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 32. United States Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023) & (K Doses)
Table 36. United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share (2018-2023)
Table 37. China Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023) & (K Doses)
Table 41. China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023) & (K Doses)
Table 46. Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share (2018-2023)
Table 47. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Type (2018-2023) & (K Doses)
Table 49. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Type (2024-2029) & (K Doses)
Table 50. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 53. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 54. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Application (2018-2023) & (K Doses)
Table 56. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Application (2024-2029) & (K Doses)
Table 57. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 60. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 61. Zoetis Animal Health Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Animal Health Major Business
Table 63. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 64. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Animal Health Recent Developments/Updates
Table 66. Zoetis Animal Health Competitive Strengths & Weaknesses
Table 67. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer-Ingelheim Major Business
Table 69. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 70. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Boehringer-Ingelheim Recent Developments/Updates
Table 72. Boehringer-Ingelheim Competitive Strengths & Weaknesses
Table 73. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 74. Merck Animal Health Major Business
Table 75. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 76. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Merck Animal Health Recent Developments/Updates
Table 78. Merck Animal Health Competitive Strengths & Weaknesses
Table 79. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 80. Ceva Sant? Animale Major Business
Table 81. Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 82. Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Ceva Sant? Animale Recent Developments/Updates
Table 84. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 85. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 86. MSD Animal Health Major Business
Table 87. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 88. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. MSD Animal Health Recent Developments/Updates
Table 90. MSD Animal Health Competitive Strengths & Weaknesses
Table 91. SPAH Basic Information, Manufacturing Base and Competitors
Table 92. SPAH Major Business
Table 93. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 94. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. SPAH Recent Developments/Updates
Table 96. SPAH Competitive Strengths & Weaknesses
Table 97. Nanjing Tianbang Biological Technology Basic Information, Manufacturing Base and Competitors
Table 98. Nanjing Tianbang Biological Technology Major Business
Table 99. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 100. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 102. Nanjing Tianbang Biological Technology Competitive Strengths & Weaknesses
Table 103. Sichuan Huapai Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Sichuan Huapai Bio-pharmaceutical Major Business
Table 105. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 106. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
Table 108. Sichuan Huapai Bio-pharmaceutical Competitive Strengths & Weaknesses
Table 109. Guangdong Winsun Bio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Guangdong Winsun Bio Pharmaceutical Major Business
Table 111. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 112. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
Table 114. Guangdong Winsun Bio Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 116. Wuhan Keqian Biology Major Business
Table 117. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 118. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Wuhan Keqian Biology Recent Developments/Updates
Table 120. Wuhan Keqian Biology Competitive Strengths & Weaknesses
Table 121. Shanghai Hile Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Hile Bio-Technology Major Business
Table 123. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 124. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 126. Shanghai Hile Bio-Technology Competitive Strengths & Weaknesses
Table 127. Harbin Pharmaceutical Group Bio-Vaccine Basic Information, Manufacturing Base and Competitors
Table 128. Harbin Pharmaceutical Group Bio-Vaccine Major Business
Table 129. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 130. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
Table 132. Harbin Pharmaceutical Group Bio-Vaccine Competitive Strengths & Weaknesses
Table 133. Ringpu Basic Information, Manufacturing Base and Competitors
Table 134. Ringpu Major Business
Table 135. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 136. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Ringpu Recent Developments/Updates
Table 138. Ringpu Competitive Strengths & Weaknesses
Table 139. Shandong Huahong Bioengineering Basic Information, Manufacturing Base and Competitors
Table 140. Shandong Huahong Bioengineering Major Business
Table 141. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 142. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Shandong Huahong Bioengineering Recent Developments/Updates
Table 144. Shandong Huahong Bioengineering Competitive Strengths & Weaknesses
Table 145. Weike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 146. Weike Biotechnology Major Business
Table 147. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 148. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Weike Biotechnology Recent Developments/Updates
Table 150. Weike Biotechnology Competitive Strengths & Weaknesses
Table 151. Nanjing Tianbang Biological Technology Basic Information, Manufacturing Base and Competitors
Table 152. Nanjing Tianbang Biological Technology Major Business
Table 153. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 154. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 156. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 157. China Animal Husbandry Industry Major Business
Table 158. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 159. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Upstream (Raw Materials)
Table 161. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Typical Customers
Table 162. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Typical Distributors
Table 1. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Region (2018-2023) & (K Doses)
Table 7. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Region (2024-2029) & (K Doses)
Table 8. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share by Region (2018-2023)
Table 9. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share by Region (2024-2029)
Table 10. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 11. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 12. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Major Market Trends
Table 13. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Doses)
Table 14. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption by Region (2018-2023) & (K Doses)
Table 15. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Forecast by Region (2024-2029) & (K Doses)
Table 16. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Producers in 2022
Table 18. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Manufacturer (2018-2023) & (K Doses)
Table 19. Production Market Share of Key Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Producers in 2022
Table 20. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 21. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Company Evaluation Quadrant
Table 22. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Site of Key Manufacturer
Table 24. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Type Footprint
Table 25. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Application Footprint
Table 26. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Competitive Factors
Table 27. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine New Entrant and Capacity Expansion Plans
Table 28. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 31. United States VS China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 32. United States Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023) & (K Doses)
Table 36. United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share (2018-2023)
Table 37. China Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023) & (K Doses)
Table 41. China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2023) & (K Doses)
Table 46. Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share (2018-2023)
Table 47. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Type (2018-2023) & (K Doses)
Table 49. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Type (2024-2029) & (K Doses)
Table 50. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 53. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 54. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Application (2018-2023) & (K Doses)
Table 56. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production by Application (2024-2029) & (K Doses)
Table 57. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 60. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 61. Zoetis Animal Health Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Animal Health Major Business
Table 63. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 64. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Animal Health Recent Developments/Updates
Table 66. Zoetis Animal Health Competitive Strengths & Weaknesses
Table 67. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer-Ingelheim Major Business
Table 69. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 70. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Boehringer-Ingelheim Recent Developments/Updates
Table 72. Boehringer-Ingelheim Competitive Strengths & Weaknesses
Table 73. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 74. Merck Animal Health Major Business
Table 75. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 76. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Merck Animal Health Recent Developments/Updates
Table 78. Merck Animal Health Competitive Strengths & Weaknesses
Table 79. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 80. Ceva Sant? Animale Major Business
Table 81. Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 82. Ceva Sant? Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Ceva Sant? Animale Recent Developments/Updates
Table 84. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 85. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 86. MSD Animal Health Major Business
Table 87. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 88. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. MSD Animal Health Recent Developments/Updates
Table 90. MSD Animal Health Competitive Strengths & Weaknesses
Table 91. SPAH Basic Information, Manufacturing Base and Competitors
Table 92. SPAH Major Business
Table 93. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 94. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. SPAH Recent Developments/Updates
Table 96. SPAH Competitive Strengths & Weaknesses
Table 97. Nanjing Tianbang Biological Technology Basic Information, Manufacturing Base and Competitors
Table 98. Nanjing Tianbang Biological Technology Major Business
Table 99. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 100. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 102. Nanjing Tianbang Biological Technology Competitive Strengths & Weaknesses
Table 103. Sichuan Huapai Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Sichuan Huapai Bio-pharmaceutical Major Business
Table 105. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 106. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
Table 108. Sichuan Huapai Bio-pharmaceutical Competitive Strengths & Weaknesses
Table 109. Guangdong Winsun Bio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Guangdong Winsun Bio Pharmaceutical Major Business
Table 111. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 112. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
Table 114. Guangdong Winsun Bio Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 116. Wuhan Keqian Biology Major Business
Table 117. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 118. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Wuhan Keqian Biology Recent Developments/Updates
Table 120. Wuhan Keqian Biology Competitive Strengths & Weaknesses
Table 121. Shanghai Hile Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Hile Bio-Technology Major Business
Table 123. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 124. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 126. Shanghai Hile Bio-Technology Competitive Strengths & Weaknesses
Table 127. Harbin Pharmaceutical Group Bio-Vaccine Basic Information, Manufacturing Base and Competitors
Table 128. Harbin Pharmaceutical Group Bio-Vaccine Major Business
Table 129. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 130. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
Table 132. Harbin Pharmaceutical Group Bio-Vaccine Competitive Strengths & Weaknesses
Table 133. Ringpu Basic Information, Manufacturing Base and Competitors
Table 134. Ringpu Major Business
Table 135. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 136. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Ringpu Recent Developments/Updates
Table 138. Ringpu Competitive Strengths & Weaknesses
Table 139. Shandong Huahong Bioengineering Basic Information, Manufacturing Base and Competitors
Table 140. Shandong Huahong Bioengineering Major Business
Table 141. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 142. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Shandong Huahong Bioengineering Recent Developments/Updates
Table 144. Shandong Huahong Bioengineering Competitive Strengths & Weaknesses
Table 145. Weike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 146. Weike Biotechnology Major Business
Table 147. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 148. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Weike Biotechnology Recent Developments/Updates
Table 150. Weike Biotechnology Competitive Strengths & Weaknesses
Table 151. Nanjing Tianbang Biological Technology Basic Information, Manufacturing Base and Competitors
Table 152. Nanjing Tianbang Biological Technology Major Business
Table 153. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 154. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 156. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 157. China Animal Husbandry Industry Major Business
Table 158. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 159. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Upstream (Raw Materials)
Table 161. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Typical Customers
Table 162. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Picture
Figure 2. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029) & (K Doses)
Figure 5. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 6. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029) & (K Doses)
Figure 9. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029) & (K Doses)
Figure 10. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029) & (K Doses)
Figure 11. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029) & (K Doses)
Figure 12. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 15. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 17. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 18. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 19. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 20. South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 21. ASEAN Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 22. India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 23. Producer Shipments of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Markets in 2022
Figure 26. United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share 2022
Figure 32. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Type in 2022
Figure 34. Live Vaccine
Figure 35. Inactivated Vaccine
Figure 36. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 39. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Application in 2022
Figure 41. Piglets
Figure 42. Adults Pigs
Figure 43. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 46. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Chain
Figure 47. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Procurement Model
Figure 48. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Model
Figure 49. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Picture
Figure 2. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029) & (K Doses)
Figure 5. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 6. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029) & (K Doses)
Figure 9. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029) & (K Doses)
Figure 10. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029) & (K Doses)
Figure 11. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production (2018-2029) & (K Doses)
Figure 12. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 15. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 17. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 18. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 19. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 20. South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 21. ASEAN Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 22. India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption (2018-2029) & (K Doses)
Figure 23. Producer Shipments of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Markets in 2022
Figure 26. United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share 2022
Figure 32. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Type in 2022
Figure 34. Live Vaccine
Figure 35. Inactivated Vaccine
Figure 36. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 39. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Application in 2022
Figure 41. Piglets
Figure 42. Adults Pigs
Figure 43. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 46. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Chain
Figure 47. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Procurement Model
Figure 48. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Model
Figure 49. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
